Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark Wilkinson

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|June 6, 2015
Diagnostic accuracy of bone turnover markers as a screening tool for aseptic loosening after total hip arthroplastyNeil R Lawrence, Raveen L Jayasuriya, Fatma Gossiel, et al.
International Journal of Molecular Sciences|June 2, 2021
Distinct Concentration-Dependent Molecular Pathways Regulate Bone Cell Responses to Cobalt and Chromium Exposure from Joint Replacement ProsthesesKaran M Shah, Mark J Dunning, Alison Gartland, et al.
Bone|June 22, 2011
Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal healthRebecca E Andrews, Karan M Shah, J Mark Wilkinson, et al.
EFORT Open Reviews|June 19, 2019
Orthopaedic registries - the UK view (National Joint Registry): impact on practiceMartyn Porter, Richard Armstrong, Peter Howard, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 12, 2003
Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplastyJ Mark Wilkinson, Andrew J Hamer, Angela Rogers, et al.
Human Molecular Genetics|July 9, 2015
Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritisSarah Hawtree, Munitta Muthana, J Mark Wilkinson, et al.
Plos One|September 27, 2013
A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activationEndre Kiss-Toth, Edward Harlock, Darren Lath, et al.
Arthritis and Rheumatism|December 2, 2009
Reply to letter by Gallo and Petrek commenting on interleukin-1 receptor antagonist and interleukin-6 polymorphisms and post-total hip arthroplasty osteolysisA Gordon, E Kiss-Toth, Ian Stockley, et al.
Arthritis and Rheumatism|September 30, 2008
Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplastyAndrew Gordon, E Kiss-Toth, Ian Stockley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 24, 2021
Genetic and Epigenetic Interplay Within a COLGALT2 Enhancer Associated With OsteoarthritisYulia S Kehayova, Emily Watson, J Mark Wilkinson, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|June 6, 2015
Diagnostic accuracy of bone turnover markers as a screening tool for aseptic loosening after total hip arthroplastyNeil R Lawrence, Raveen L Jayasuriya, Fatma Gossiel, et al.
International Journal of Molecular Sciences|June 2, 2021
Distinct Concentration-Dependent Molecular Pathways Regulate Bone Cell Responses to Cobalt and Chromium Exposure from Joint Replacement ProsthesesKaran M Shah, Mark J Dunning, Alison Gartland, et al.
Bone|June 22, 2011
Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal healthRebecca E Andrews, Karan M Shah, J Mark Wilkinson, et al.
EFORT Open Reviews|June 19, 2019
Orthopaedic registries - the UK view (National Joint Registry): impact on practiceMartyn Porter, Richard Armstrong, Peter Howard, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 12, 2003
Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplastyJ Mark Wilkinson, Andrew J Hamer, Angela Rogers, et al.
Human Molecular Genetics|July 9, 2015
Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritisSarah Hawtree, Munitta Muthana, J Mark Wilkinson, et al.
Plos One|September 27, 2013
A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activationEndre Kiss-Toth, Edward Harlock, Darren Lath, et al.
Arthritis and Rheumatism|December 2, 2009
Reply to letter by Gallo and Petrek commenting on interleukin-1 receptor antagonist and interleukin-6 polymorphisms and post-total hip arthroplasty osteolysisA Gordon, E Kiss-Toth, Ian Stockley, et al.
Arthritis and Rheumatism|September 30, 2008
Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplastyAndrew Gordon, E Kiss-Toth, Ian Stockley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 24, 2021
Genetic and Epigenetic Interplay Within a COLGALT2 Enhancer Associated With OsteoarthritisYulia S Kehayova, Emily Watson, J Mark Wilkinson, et al.
Pageof 11